Case guide

Roundup at Home: Keep the Product and Use History

Keep the label and dates from the product used at home. A brand name or worker study cannot decide your own exposure or claim.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202615 sources

This may apply to you if

  • Review the exact product and exposure history.
  • Review the cancer diagnosis and date in the medical record.
  • Review earlier cases, releases and proposed class-program rules.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

International Agency for Research on Cancer · World Health Organization · Cancer agency issuing the March 2015 evaluation

Finding: The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.

IARC glyphosate evaluation, March 20, 2015 (opens in a new tab) · Mar 20, 2015 · Checked Oct 3, 2026

The evidence and its limits

National Cancer Institute and Agricultural Health Study collaborators · Journal of the National Cancer Institute · 2018

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

Design:
Cohort
Participants:
54,251 licensed pesticide applicators; 44,932 reported glyphosate use
Finding:
The cohort did not find an overall link between glyphosate use and non-Hodgkin lymphoma.
Main limitation
Exposure was self-reported in a specific work population. This observational result cannot decide what caused one person’s cancer.

Read the source: Glyphosate Use and Cancer Incidence in the Agricultural Health Study (opens in a new tab) · Checked Oct 3, 2026

International Agency for Research on Cancer, World Health Organization · 2015

IARC Monographs Volume 112 glyphosate evaluation

Design:
Agency review
Participants:
No single sample; review of human, animal and laboratory evidence
Finding:
The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.
Main limitation
Limited human evidence means other explanations for a link could not be ruled out. A hazard classification does not prove a personal cause.

Read the source: IARC Monographs Volume 112 glyphosate evaluation (opens in a new tab) · Checked Oct 3, 2026

The short answer

Which home-use details should I record?
Keep the exact product label and the dates and places you used it. Note who applied it and what you actually recall. [9]
Can a farm-worker study answer my home question?
The study followed licensed users of pesticides in two states. It does not measure each use at home. [3]
What do the agencies say about cancer?
IARC says glyphosate probably can cause cancer. EPA’s view differs and its health review is being updated. [2]
Does the 2026 ruling end every home-use claim?
The ruling bars Durnell’s cancer-label warning claim. Ask a lawyer how that specific holding affects the claim you want checked. [1]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Which home-use details should I record?

Keep the exact product label and the dates and places you used it. Note who applied it and what you actually recall.

A civil claim needs facts about the alleged harm and responsibility. Do not infer ingredients from a brand name or replace a missing label with a picture of a different product. Ask a lawyer what record could identify the product used at the time and what gaps remain.

Can a farm-worker study answer my home question?

The study followed licensed users of pesticides in two states. It does not measure each use at home.

The study found no overall link with lymphoma or its types. That belongs in a balanced review. It is not a measure of your own exposure. Tell your care team and lawyer how the product was used at home, with dates and details you actually know.

What do the agencies say about cancer?

IARC says glyphosate probably can cause cancer. EPA’s view differs and its health review is being updated.

IARC relied on limited human lymphoma evidence and enough animal evidence. Chance or other explanations were not ruled out in the human findings. EPA plans a new health review in late 2026. Neither source alone proves that a home product caused one person’s disease.

Does the 2026 ruling end every home-use claim?

The ruling bars Durnell’s cancer-label warning claim. Ask a lawyer how that specific holding affects the claim you want checked.

The Supreme Court decided Monsanto v. Durnell on June 25, 2026 and reversed the Missouri judgment. The holding should not be widened into a claim that every possible case ended. Identify the actual product and alleged duty, and ask which law applies before assuming an outcome.

Could a proposed program include a home user?

Ask a lawyer to check the actual notice and your history. Being in a class does not by itself mean you can get a payment.

The proposed program has rules on exposure dates, diagnosis, residence, earlier cases and releases. Program-choice dates are not everyone’s civil filing limit. Keep any notice you received. Ask what a release would do to your rights before relying on a settlement headline.

What records and terms should I check next?

Keep care records with the product history and any notice. Ask about a personal deadline and written legal fee terms.

Covered providers generally permit access to medical and billing records, with exceptions and possible copying fees. Ask who would receive information from an inquiry and whether representation has been accepted. A recovery share and separate expenses should be clear before you agree; no payment or intake promise follows from this guide.

Scientific evidence for this case

Roundup lawsuit: who may qualify and what happens next · Mutation Research / Reviews in Mutation Research · 2019Meta-analysis

Exposure to Glyphosate-Based Herbicides and Risk for Non-Hodgkin Lymphoma: A Meta-Analysis

41% increased risk of NHL among highest-exposed individuals (OR = 1.41, 95% CI: 1.13-1.75)

Roundup lawsuit: who may qualify and what happens next · IARC Monographs on the Evaluation of Carcinogenic Risks to Humans · 2015Meta-analysis

IARC Monograph Volume 112: Glyphosate Evaluation

Classified glyphosate as Group 2A — "probably carcinogenic to humans"

Roundup lawsuit: who may qualify and what happens next · Journal of the National Cancer Institute · 2018Cohort

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

No statistically significant overall association between glyphosate and NHL in the full cohort

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. Supreme Court: Monsanto v. Durnell, June 25, 2026; checked 2026-10-03.Supreme Court: Monsanto v. Durnell, June 25, 2026 · court
  2. IARC glyphosate evaluation, March 20, 2015; checked 2026-10-03.IARC glyphosate evaluation, March 20, 2015
  3. Andreotti and colleagues: Agricultural Health Study; checked 2026-10-03.Andreotti and colleagues: Agricultural Health Study · study
  4. EPA: glyphosate review; checked 2026-10-03.EPA: glyphosate review · regulator
  5. King v. Monsanto preliminary approval order, March 4, 2026; checked 2026-10-03.King v. Monsanto preliminary approval order, March 4, 2026 · court
  6. King fairness hearing order, August 6, 2026; checked 2026-10-03.King fairness hearing order, August 6, 2026 · court
  7. Court-authorized Weed Killer Class notice and FAQs; checked 2026-10-03.Court-authorized Weed Killer Class notice and FAQs · court
  8. HHS: Your Medical Records; checked 2026-10-03.HHS: Your Medical Records · regulator
  9. Federal courts: civil cases; checked 2026-10-03.Federal courts: civil cases · court
  10. ABA: fees paid from a successful claim; checked 2026-10-03.ABA: fees paid from a successful claim
  11. SDNY: filing time limits; checked 2026-10-03.SDNY: filing time limits · court
  12. ABA Model Rule 1.5: fees; checked 2026-10-03.ABA Model Rule 1.5: fees
  13. JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026 · court
  14. JPML Pending MDL Dockets by Actions Pending, July 1, 2026JPML Pending MDL Dockets by Actions Pending, July 1, 2026 · court
  15. JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026 · court

Checked against 12 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026